159 related articles for article (PubMed ID: 29927319)
1. Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor.
Nadella S; Burks J; Al-Sabban A; Inyang G; Wang J; Tucker RD; Zamanis ME; Bukowski W; Shivapurkar N; Smith JP
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G699-G712. PubMed ID: 29927319
[TBL] [Abstract][Full Text] [Related]
2. Implicating the cholecystokinin B receptor in liver stem cell oncogenesis.
Gay MD; Drda JC; Chen W; Huang Y; Yassin AA; Duka T; Fang H; Shivapurkar N; Smith JP
Am J Physiol Gastrointest Liver Physiol; 2024 Mar; 326(3):G291-G309. PubMed ID: 38252699
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment.
Malchiodi ZX; Cao H; Gay MD; Safronenka A; Bansal S; Tucker RD; Weinberg BA; Cheema A; Shivapurkar N; Smith JP
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638432
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic.
Jolly G; Duka T; Shivapurkar N; Chen W; Bansal S; Cheema A; Smith JP
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345148
[TBL] [Abstract][Full Text] [Related]
5. Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non-alcoholic Steatohepatitis.
Rabiee A; Gay MD; Shivapurkar N; Cao H; Nadella S; Smith CI; Lewis JH; Bansal S; Cheema A; Kwagyan J; Smith JP
Clin Pharmacol Ther; 2022 Dec; 112(6):1271-1279. PubMed ID: 36087237
[TBL] [Abstract][Full Text] [Related]
6. CCK Receptor Inhibition Reduces Pancreatic Tumor Fibrosis and Promotes Nanoparticle Delivery.
Abraham T; Armold M; McGovern C; Harms JF; Darok MC; Gigliotti C; Adair B; Gray JL; Kelly DF; Adair JH; Matters GL
Biomedicines; 2024 May; 12(5):. PubMed ID: 38790986
[TBL] [Abstract][Full Text] [Related]
7. Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases.
Osborne N; Sundseth R; Gay MD; Cao H; Tucker RD; Nadella S; Wang S; Liu X; Kroemer A; Sutton L; Cato A; Smith JP
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G682-G693. PubMed ID: 31433212
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein A-IV enhances cholecystokinnin secretion.
Zhan J; Weng J; Hunt BG; Sean Davidson W; Liu M; Lo CC
Physiol Behav; 2018 May; 188():11-17. PubMed ID: 29378187
[TBL] [Abstract][Full Text] [Related]
9. Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer.
Smith JP; Cao H; Chen W; Mahmood K; Phillips T; Sutton L; Cato A
Front Oncol; 2021; 11():788875. PubMed ID: 34926305
[TBL] [Abstract][Full Text] [Related]
10. Dietary fat and lipid metabolism in the tumor microenvironment.
Goswami S; Zhang Q; Celik CE; Reich EM; Yilmaz ÖH
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188984. PubMed ID: 37722512
[TBL] [Abstract][Full Text] [Related]
11. The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial.
Ciofoaia V; Chen W; Tarek BW; Gay M; Shivapurkar N; Smith JP
Pharmaceutics; 2024 Apr; 16(5):. PubMed ID: 38794273
[TBL] [Abstract][Full Text] [Related]
12. Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression.
Zabransky DJ; Chhabra Y; Fane ME; Kartalia E; Leatherman JM; Hüser L; Zimmerman JW; Delitto D; Han S; Armstrong TD; Charmsaz S; Guinn S; Pramod S; Thompson ED; Hughes SJ; O'Connell J; Egan JM; Jaffee EM; Weeraratna AT
Cancer Res; 2024 Apr; 84(8):1221-1236. PubMed ID: 38330147
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous Effects of Calorie Content and Nutritional Components Underlie Dietary Influence on Pancreatic Cancer Susceptibility.
Dooley J; Lagou V; Goveia J; Ulrich A; Rohlenova K; Heirman N; Karakach T; Lampi Y; Khan S; Wang J; Dresselaers T; Himmelreich U; Gunter MJ; Prokopenko I; Carmeliet P; Liston A
Cell Rep; 2020 Jul; 32(2):107880. PubMed ID: 32668252
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Cholecystokinin-Secretory Peptides Using Bidirectional Long Short-term Memory Model Based on Transfer Learning and Hierarchical Attention Network Mechanism.
Liu J; Chen P; Song H; Zhang P; Wang M; Sun Z; Guan X
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759772
[TBL] [Abstract][Full Text] [Related]
15. Germline Mutation of the CCK Receptor: A Novel Biomarker for Pancreas Cancer.
Alsubai J; Matters GL; McGovern CO; Liao J; Gilius EL; Smith JP
Clin Transl Gastroenterol; 2016 Jan; 7(1):e134. PubMed ID: 26741064
[TBL] [Abstract][Full Text] [Related]
16. Editorial: Mechanism and treatment for pancreatic cancer metastases.
Guo W; Wu D; Xu J; Wang L
Front Oncol; 2024; 14():1424817. PubMed ID: 38807766
[No Abstract] [Full Text] [Related]
17. Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis.
Astuti Y; Raymant M; Quaranta V; Clarke K; Abudula M; Smith O; Bellomo G; Chandran-Gorner V; Nourse C; Halloran C; Ghaneh P; Palmer D; Jones RP; Campbell F; Pollard JW; Morton JP; Mielgo A; Schmid MC
Nat Cancer; 2024 May; 5(5):808. PubMed ID: 38472300
[No Abstract] [Full Text] [Related]
18. Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer.
Burks J; Nadella S; Mahmud A; Mankongpaisarnrung C; Wang J; Hahm JI; Tucker RD; Shivapurkar N; Stern ST; Smith JP
Cell Mol Gastroenterol Hepatol; 2018; 6(1):17-32. PubMed ID: 29928669
[TBL] [Abstract][Full Text] [Related]
19. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin Receptor Antagonist Therapy Decreases Inflammation and Fibrosis in Chronic Pancreatitis.
Nadella S; Ciofoaia V; Cao H; Kallakury B; Tucker RD; Smith JP
Dig Dis Sci; 2020 May; 65(5):1376-1384. PubMed ID: 31598921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
